Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
|
|
- Joan Parks
- 5 years ago
- Views:
Transcription
1 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written terms of reference are in the process of being adopted. A national system to monitor adverse events following immunization (AEFI) exists. A national policy for health care waste management including waste from immunization activities exists. All 36 States and Union Territories have achieved MNT elimination status by May 5. 78% spending on vaccines financed by the government. 78% spending on routine immunization programme financed by the government. JE campaign conducted in March 4-January 5, targeting 5,37,773 children of -5 years of age, and coverage was 87%. No stock-out of vaccines reported in 4. Effective vaccine management assessment done in states. In 4 eleven states/ UTs conducted validation of maternal and neonatal tetanus elimination. Introduced polio vaccination policy for travellers to and from polio endemic/infected countries in 4. Post introduction evaluation for DTP-Hib-HepB and MCV was conducted in six states / UTs in 4. Plan to introduce IPV in October 5 and Rubella & Rotavirus vaccines in 5. Mission Indradhanush to immunize all children against 7 VPDs was launched in December 4. Table : Basic information 4 Total population,65,38, Live births (LB) 7,6, Children < year 5,98, Children <5 years 3,88, Children <5 years 5,639, Pregnant women 9,78, Women of child bearing age (5-49 years) Neonatal mortality rate Infant mortality rate Vaccine BCG HepB OPV DTP DTP-Hib- HepB Measles JE TT Vitamin A Age of administration At birth At birth, 6th, th and 4th weeks At birth, 6th, th, 4th weeks and 6-4 months 6th, th, 4th weeks, 6-4 months and 5-6 years 6th, th, 4th weeks (selected states) 9 months and 6-4 months 3,46,3 9 (per, LB) 4 (per, LB) Under-five mortality rate 5 (per, LB) Maternal mortality ratio 78 (per, LB) SEAR annual EPI reporting form, 4 and WHO, World Health Statistics 4 Table : Immunization schedule, 4 9- months and 6-4 months (JE endemic districts) years, 6 years and doses/booster for pregnant women 9 months, 8 months and 6 months interval till age 5 years Source: WHO/UNICEF joint reporting form (JRF) 4 Division/Province/State/Region 36 District 674 Block 5958 Population density (per sq. km) 38 Population living in urban areas 3% Population using improved drinking-water sources 93% Population using improved sanitation 36% Total expenditure on health as % of GDP 3.9% Births attended by skilled health personnel 3 67% Neonates protected at birth against NT 87% 3 Institutional births (WHS, 4) EPI history Vaccination practiced in India since the early 9s. BCG introduced in 96. EPI was launched in 8 with DPT, OPV, BCG and typhoid. TT immunization of pregnant women was introduced in 3. Measles was introduced in 5. HepB piloted in and made universal in. MCV introduced in. Hib Pentavalent (DTP-Hib-HepB) introduced in two states in and gradually expanded to eight states in 3. Two doses of JE (9- months and 6-4 months) introduced in 3 in endemic districts. Open vial policy introduced in 3. Source: cmyp 3-7 and EPI/MoHFW Disclaimer: The boundaries and names shown and the designations used on all the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. World Health Organization SEARO/FHR/IVD July 5 Immunization and Vaccine Development South-East Asia Region
2 E P I FAC T S H E E T Figure : DTP3 coverage, diphtheria and pertussis, BCG DTP3 OPV3 MCV Diphtheria Cases Source: WHO/UNICEF coverage estimates. Figure 3: DTP-Hib-HepB3 coverage, Pertussis Cases DTP3 Coverage WHO/UNICEF coverage estimates. WHO vaccine-preventable diseases: monitoring system 4 & JRF 4. Figure 4: TT+ coverage and NT, NT <7% 7% - 79% 8% - 89% TT+ Coverage Country official estimates, -4. WHO vaccine-preventable diseases: monitoring system 4 & JRF 4. > 9% Source: SEAR annual EPI reporting form, 4 (administrative data) Table 3: OPV supplementary immunization activities (SIA), -4 Start date Activity Children immunized (<5 years) Coverage based on independent monitoring (%) Start date Activity Children immunized (<5 years) Coverage based on independent monitoring (%) 5-Jan- 9-Feb- 8,77,574 7-Apr-3 7,746,34 68,69,78 6-Jun-3 7,3,7 8-Mar- 55,78,79 5-Sep-3 7,38,3 5-Apr- 68,,45 4-Nov-3 7,78,96 7-Jun- 7,89,49 9-Jan-4 67,89,448 9-Sep- 7,365,94 3-Jan-4 68,48,57 4-Nov- 7,455,848 6-Apr-4 46,879,86 -Jan-3 67,47,68 -Sep-4 7,8,98 4-Feb-3 68,5,3 6-Nov-4 7,564,88 Source: NCCPE reports and WHO/UNICEF JRF World Health Organization SEARO/FHR/IVD July 5 Figure : National immunization coverage, -4
3 Table 4: AFP surveillance performance indicators, 5-4 The last polio case due to wild polio virus (WPV) was reported on 3 January from West Bengal. Indicator AFP 7,49 3,94 4,54 45,585 5,45 55,785 6,54 6,9 54,66 54, Wild poliovirus confirmed Compatible AFP rate Non-polio AFP rate Adequate stool specimen collection percentage 8% 8% 84% 84% % % 84% 87% 86% 87% Total stool samples collected 5,56 6,649 8,64 88,36,648 8,7 7,774 9,39,4 5,939 % NPEV isolation % Timeliness of primary result reported Number of discarded AFP per, children under 5 years of age. Percent with specimens, 4 hours apart and within 4 days of paralysis onset. 3 5 to 7 result reported within 8 days and 8 onwards result reported within 4 days of sample received at laboratory. Figure 5: Non-polio AFP rate by district, 4 Figure 6: Adequate stool specimen collection percentage by district, 4 <. > No non-polio AFP case < 6% 6% 79% > 8% No AFP Source: Weekly Acute Flaccid Paralysis (AFP) data Polio Diphtheria Pertussis Neonatal Tetanus (% of all Tetanus) Source: Weekly Acute Flaccid Paralysis (AFP) data Table 5: Reported of vaccine preventable disease, 5-4 Measles Rubella Mumps Japanese Encephalitis Congenital Rubella Syndrome ,86 3, 8 (8%) 36,7 ND ND ND ND 6 676,4 3,88 65 (%) 64,85 ND ND ND ND ,8 46,674,76 (4%) 4,44 ND ND 4,7 ND ,7 43,6 876 (3%) 44,58 ND ND 47 ND 9 74 a 3,59 6,385 8 (4%) 56,88 ND ND 653 ND 4 b 3,434 4,58 5 (3%) 3,458 ND ND 555 ND c 4,33 39,9 734 (6%) 33,634 ND ND,4 ND d,55 44, (4%) 8,668,3 ND ND ND 3 e 3,33 3,89 45 (5%) 3,8 3,6 ND,78 ND 4 f 6,94 46,76 49(%) 4,7 487 ND 657 ND a Excludes two type VDPV and nineteen type VDPV b Excludes five type VDPV c Excludes six type VDPV and one type 3 VDPV d Excludes one type VDPV e Excludes five type VDPV f Excludes three type VDPV Source: WHO/UNICEF JRF ND=No data
4 Figure 7: MCV & MCV coverage and, -4 Figure 8: MCV coverage by province, Measles Cases MCV Coverage MCV coverage WHO/UNICEF coverage estimates. WHO vaccine-preventable diseases: monitoring system 4 & JRF 4. <7% 7% - 79% 8% - 89% > 9% Source: SEAR annual EPI reporting form, 4 (administrative data) Table 6: MCV supplementary immunization activities Table 7: Provinces with more than 95% MCV coverage Vaccine, geographic coverage, target group Target Coverage Achieved Number of provinces % M, sub-national, 9 months to years M, sub-national, 9 months to years M, sub-national, 9 months to years 3,845,686 87% 4,67,58 9% 76,73,639 9% Source: WHO/UNICEF JRFs Source: WHO/UNICEF JRF (multiple years) Figure 9: Sporadic and outbreak associated * by month and MR SIA coverage, -4 4 M, follow up (%) Jan- Feb- Mar- Apr- May- Jun- Jul- Aug- Sep- Oct- Nov- Dec- Jan- Feb- Mar- Apr- May- Jun- Jul- Aug- Sep- Oct- Nov- Dec- Jan- Feb- Mar- Apr- May- Jun- Jul- Aug- Sep- Oct- Nov- Dec- Jan-3 Feb-3 Mar-3 Apr-3 May-3 Jun-3 Jul-3 Aug-3 Sep-3 Oct-3 Nov-3 Dec-3 Jan-4 Feb-4 Mar-4 Apr-4 May-4 Jun-4 Jul-4 Aug-4 Sep-4 Oct-4 Nov-4 Dec-4 Sporadic Outbreak associated *Includes laboratory confirmed and epidemiologically linked Source: SEAR Monthly VPD reports Immunization and Vaccine Development South-East Asia Region
5 Figure : Immunity against : Immunity profile by age in 5* Percent of population % 9% 8% 7% 6% 5% 4% 3% % % % Age (in years) Protected by maternal antibodies Protected by routine vaccination with nd dose Immune due to past infection Protected by routine vaccination with st dose Protected by SIAs Susceptible * Based on coverage data up to 4 with approximately 48% children aged 9 months to years reached with SIA between -. Source: Modeled using MSP tool ver Figure : Immunity against : Immunity profile by age in 6* Percent of population % 8% 6% 4% % % Age (in years) Protected by maternal antibodies Protected by routine vaccination with st dose Protected by routine vaccination with nd dose Protected by SIAs Immune due to past infection Susceptible * Assuming the schedule and coverage of Measles containing vaccine is unchanged in 5. Source: Modeled using MSP tool ver Figure : Confirmed (Lab and Epi linked) outbreak associated, by age, -4 Figure 3: Unimmunized confirmed (Lab and Epi linked) outbreak associated, by age, -4 8 n=84 n=8589 n=58 n=6485 n=4 n=765 n=355 n=79 n=3884 n=3758 (34%) (38%) (69%) (6%) (55%) < year -4 years 5-9 years -4 years 5+ years < year -4 years 5-9 years -4 years 5+ years Source: SEAR annual EPI reporting form (multiple years) Source: SEAR annual EPI reporting form (multiple years) Table 8: Suspected sporadic and Outbreak associated and rubella, -4 Routine/sporadic Outbreak associated suspected case death labconfirmed labconfirmed rubella suspected outbreak Outbreak Investigated case death outbreak* confirmed case* confirmed rubella outbreak* confirmed rubella * 7, , , , ,85 5 3,7 5,38,3 3, , ,34 6,86 3 6, , ,858 7, ,93 - -,69, 34, ,44 4,3 Source: Monthly VPD Reporting to WHO/SEARO * Laboratory confirmed & epidemiologically- linked
6 EPI FACT SHEET Table 9: Quality of field and laboratory surveillance for and rubella, -4 Case classification (number) Indicators Suspected Measles Lab-confirmed Measles Epi-Linked Clinically-confirmed Rubella Lab-confirmed Epi-Linked Discarded non- non-rubella Annual incidence of confirmed Measles per million total population Annual incidence of confirmed Rubella per million total population Proportion of all suspected and rubella that have had an adequate investigation initiated within 48 hours of notification Discarded non- non-rubella incidence per, total population Proportion of subnational administrative units reporting at least two discarded non- non-rubella per, total population Proportion of sub-national surveillance units reporting to the national level on time Target - - 8% 8% 8% 3, ,89, ,74 9 6,3-373,4, ,93 3,3, ,35, Source: SEAR Annual EPI Reporting Form, 4 ND=No data Table : Performance of Laboratory Surveillance, -4 % Serum specimen collected from suspected Total Serum Specimen received in Laboratory % serum specimens tested Specimen Positive for Measles IgM Specimen Positive for Rubella IgM % Results within 4 of receipt % Outbreak tested for viral detection Genotypes detected No. % No. % Measles Rubella D , D8 B ,473.73, D4,D8,B3 Source: SEAR Annual EPI Reporting Form, 4 ND=No data Figure 4: Network of WHO supported surveillance medical officers and laboratories, 4 Surveillance medical officers Laboratories: Polio Measles/rubella Polio and /rubella Japanese encephalitis IBD and Rotavirus reference Lab Source: WHO/NPSP and SEARO For contact or feedback: Immunization Division Ministry of Health and Family Welfare (MOHFW), New Delhi, India Tel/Fax : , pradeephaldar@yahoo.co.in Immunization and Vaccine Development (IVD) WHO-SEARO, IP Estate, MG Marg, New Delhi, India Tel: , Fax: SEAREpidata@who.int, World Health Organization SEARO/FHR/IVD July 5 Immunization and Vaccine Development South-East Asia Region
Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
More informationTotal population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
More informationTotal population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
More informationTable 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.
EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationTable 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
More informationExpanded Programme on Immunization (EPI)
Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationTable 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210
EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine
More informationExpanded Programme on Immunization (EPI)
Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationTable 1: Basic information 2017
EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB
More informationExpanded Programme on Immunization (EPI)
Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing
More informationImmunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: January 03, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
More informationMonthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: May 11, 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
More informationMonthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO
Monthly Vaccine Preventable Disease and Immunization Update Published: March 10, 2015 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus
More informationImmunization and Vaccine Development (IVD) SEARO
VPD Update for Week 33, 2014 Data as of 18 August 2014 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus case by type, SEAR WPV Type
More informationAddendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)
Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Background India was certified polio-free along with 10 other countries of WHO South-East Asia Region
More informationMeasles and Rubella Fact Sheet SEAR #
and Fact Sheet SEAR 8-9 Table : South-East Asia Regional (SEAR) Strategic Plan 7- Goal: To reduce the number of measles deaths by 9 in relative to estimates. Objectives: Achieve at least 9 national Containing
More informationThe Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
More informationVPD in Mediterranean Basin and Black Sea: the Polio case
Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio
More informationHighlighting in the WHO European Region: Summary. No. 21(February 2012)
No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationThe State of Measles and Rubella in the WHO European Region
The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual
More information宮村参考人提出資料 資料 2-2
宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar
More informationVaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO
Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/
More informationTargeted Diseases and Immunization. Strategic plan
Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationEthics Perspective of Immunisation Programs
Ethics Perspective of Immunisation Programs with special reference to Herd Effect T Jacob John Vellore, India Annecy 26 October 2010 Defining Herd immunity and Herd effect. Between participants and nonparticipants
More informationTable 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,
Volume 7 Issue 5 May 2013 ISSN 1814 3601 Table 1. case classification and by country and area, WHO Western Pacific Region, 2008 2013 1 confirmed 2 2 009 per confirmed 2 2 010 2 011 2 012 2013 1 Confirmed
More informationAIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO
POLIO FAQs on ENDGAME Tuberculosis AIDA M. SALONGA, MD, FPNA, FCNSP CHAIR, AFP EXPERT PANEL, DOH MEMBER, REGIONAL CERTIFICATION COMMITTEE, WHO OBJECTIVES Brief history of poliomyelitis Polio eradication:
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationGlobal Report to SAGE. Fulfillment of previous recommendations & progress highlights
Global Report to SAGE Fulfillment of previous recommendations & progress highlights SAGE Meeting, 8-10 November 2012 J.M. Okwo-Bele, WHO Outline 1 2 3 4 Global progress Regional updates- RTAGs recommendations
More informationVPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO
VPD Update for Week 1, 2018 Data as of 8 January 2018 Immunization and Vaccine Development (IVD) SEARO Protecting People from Vaccine Preventable Diseases Last wild poliovirus cases confirmed by type,
More informationPOLIO ERADICATION AND POST-CERTIFICATION STRATEGY
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand
More informationFigure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region
Volume 12 Issue 4 April ISSN 1814 3601 Figure 1. Incidence rate of total ( compatible) measles cases with rash onset 1 31 ch, WHO Western Pacific Region Legend: No cases
More informationIEAG Findings 5-6 December 2005
IEAG Findings 5-6 December 005 Surveillance Quality Surveillance Indicators India 005* 5.47 8% Less than 60% 60% to 69% 70% to 79% 80% and above No AFP case * data as on 6th November 005 AFP cases India
More informationEvaluating Immunisation Dropout Rates in Eight Hard to Reach Unions of Maulvibazar District, Bangladesh
International Journal of Immunology 2017; 5(1): 5-10 http://www.sciencepublishinggroup.com/j/iji doi: 10.11648/j.iji.20170501.12 ISSN: 2329-177X (Print); ISSN: 2329-1753 (Online) Evaluating Immunisation
More informationKURUKSHETRA JULY 2017 RURAL HEALTH
KURUKSHETRA JULY 2017 RURAL HEALTH Jagat Prakash Nadda is the Union Minister of Health and Family Welfare. Immunization, or immunisation, is the process by which an individual's immune system becomes
More informationEPI and VPD Surveillance Review and Post-Introduction Evaluation of Hib (Pentavalent) Vaccine
EPI and VPD Surveillance Review and Post-Introduction Evaluation of Hib (Pentavalent) Vaccine Report of the Mission Bangladesh, 15-25 March 2012 Regional Office for South-East Asia SEA-Immun-67 Distribution:
More informationMeasles and Rubella Global Update SAGE 19 October 2017
Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella
More informationLegend: No confirmed case With confirmed case No case based data
Volume 11 Issue 3 ch ISSN 1814 3601 Figure 1. Distribution of measles cases with rash onset 1 28 ruary, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at random
More informationGlobal ProhrammeUpdate?
Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus
More informationOF MEASLES ELIMINATION
GUIDELINES ON VERIFICATION OF MEASLES ELIMINATION IN THE WESTERN PACIFIC REGION 2013 GUIDELINES ON VERIFICATION OF MEASLES ELIMINATION IN THE WESTERN PACIFIC REGION WHO Library Cataloguing-in-Publication
More informationGlobal and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018
Global and Regional update on Polio Eradication Activities Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Presentation Outline 1. Background information 2. Poliovirus detection & interruption
More informationNational HPV Vaccine Coverage, WHO- UNICEF Joint Reporting Form
resource from : Evaluating HPV vaccination pilots: practical experience from path publication title National HPV Vaccine Coverage, WHO- UNICEF Joint Reporting Form publisher WHO/UNICEF publication date
More informationGlobal Polio Partners Group Monitoring Framework for the GPEI Polio Eradication & Endgame Strategic Plan
Global Polio Partners Group Monitoring Framework for the GPEI Polio Eradication & Endgame Strategic Plan High Level Meeting of the Global Polio Partners Group (PPG) 16 June 2014 Objectives Explain the
More informationYear: 2017 Volume:5 Issue-1 Introduction of newer vaccines in Immunization Programme of India: Challenges to be addressed
Editorial Year: 2017 Volume:5 Issue-1 Introduction of newer vaccines in Immunization Programme of India: Challenges to be addressed Dr. Samir Dasgupta1 1 Professor & Head, Department of Community Medicine,
More informationAnalysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage
A MONTHLY NEWSLETTER OF THE COMMUNICABLE DISEASE UNIT, WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE, COPENHAGEN, DENMARK Issue 5, March 2009 Analysis of 3-dose oral/inactivated poliovirus vaccine
More informationGlobal Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
More informationProtecting people from Vaccine Preventable Diseases
Protecting people from Vaccine Preventable Diseases Immunization and Vaccine Development South East Asia Region Strategic Plan (2010 2013) Table of Contents INTRODUCTION...2 1. THE IVD MISSION IN THE GLOBAL
More informationGlobal Polio Eradication & Endgame Strategy. December 2015
Global Polio Eradication & Endgame Strategy December 2015 Poliovirus detection & interruption OPV withdrawal, IPV introduction, RI strengthening Containment & Global Certification Legacy Planning Polio
More informationJoint National/International Expanded Programme on Immunization and Vaccine Preventable Disease Surveillance Review
SEA-Immun-97 Distribution: General Joint National/International Expanded Programme on Immunization and Vaccine Preventable Disease Surveillance Review Democratic Socialist Republic of 16 26 October 2015
More informationJoint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal
SEA Polio 44 Distribution: Limited Joint National/International Review of Acute Flaccid Paralysis (AFP) Surveillance Nepal 25 March 6 April 2006 and 6-12 August 2006 World Health Organization This document
More informationGlobal and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.
Global and National Trends in Vaccine Preventable Diseases Dr Brenda Corcoran National Immunisation Office Global mortality 2008 Children under 5 years of age 1.5 million deaths due to vaccine preventable
More informationAfghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data
More informationSouth-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Meeting Report
The eighth meeting of the World Health Organization's South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) was held from 13 to 16 June 2017 in New Delhi, India. SEAR-ITAG is a technical
More informationImpact of Immunization on Under 5 Mortality
Annals of Community Health (AoCH) pissn 2347-5455 eissn 2347-5714 An Indexed (Index Medicus, DOAJ and More), Peer Reviewed, Quarterly, International Journal focusing exclusively on Community Medicine and
More informationGlobal landscape analysis and literature review of 2 nd Year of Life immunization platform
Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina
More informationHighlighting in the WHO European Region:
No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European
More informationUIP FACT SHEET. Socio - demographic profile PRL. Infant Mortality Rate
UIP FACT SHEET WEST BENGAL Census 1 Total Population 8,176,197 Population--6yr 11,414,222 Literacy Rate 68.6 Sex Ratio 934 Sex Ratio -6 yr 96 Socio - demographic profile Census 11 91,347,736 1,112,599
More informationMeasles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
More informationWHO Library Cataloguing-in-Publication Data. World health statistics 2011.
WORLD HEALTH STATISTICS 2011 WHO Library Cataloguing-in-Publication Data World health statistics 2011. 1.Health status indicators. 2.World health. 3.Health services - statistics. 4.Mortality. 5.Morbidity.
More information3. CONCLUSIONS AND RECOMMENDATIONS
3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the
More informationSEA-Immun-105 Distribution: General. WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG)
SEA-Immun-105 Distribution: General WHO South-East Asia Regional Immunization Technical Advisory Group (SEAR-ITAG) Report of the Seventh Meeting of SEAR-ITAG New Delhi, India, 7 10 June 2016 World Health
More informationUpdate on Progress and Challenges in Achieving Measles and Rubella Targets
Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets
More informationLegend: No confirmed case With confirmed case** No case based data
Volume 11 Issue 9 September ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 31 ust, WHO Western Pacific Region Legend: No case With case** No case based data Dots are placed at rom within
More informationGAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012
GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012 ADRESSING CHALLENGES TO SUSTAINABLE NEW VACCINE INTRODUCTION: PERSPECTIVE FROM MONGOLIA N.UDVAL, MD, Sc D MINISTER OF HEALTH MONGOLIA CONTENT
More informationVII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE 7. 7
VII THE CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE IMMUNISATION PROGRAMME IN 2002 7. 7 The childhood immunisation programme in Singapore offers vaccination against tuberculosis, hepatitis B, diphtheria,
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationREPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING July 2008 Bangkok, Thailand
1 REPORT Of the FIRST SOUTH-EAST ASIA REGIONAL TECHNICAL ADVISORY GROUP ON IMMUNIZATION (SEAR ITAG) MEETING 14-15 July 2008 Bangkok, Thailand 2 First South-East Asia Regional Technical Advisory Group on
More informationWORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC
WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR THE WESTERN PACIFIC REPORT SIXTEENTH MEETING OF THE TECHNICAL ADVISORY GROUP ON IMMUNIZATION AND VACCINE PREVENTABLE DISEASES IN THE WESTERN PACIFIC REGION
More informationTask Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting
Task Force on Immunization (TFI) in Africa 14 th Annual Meeting And Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting Meeting Report Maputo, Mozambique 27 29 November 2006
More information@GaviSeth. Report from Gavi. Seth Berkley, CEO Meeting of the Strategic Advisory Group of Experts on Immunization April
1 @GaviSeth Report from Gavi Seth Berkley, CEO Meeting of the Strategic Advisory Group of Experts on Immunization April 2016 www.gavi.org Why SAGE matters to Gavi Gavi relies on SAGE technical guidance
More informationThank you for joining, the M&RI webinar will begin shortly
Thank you for joining, the M&RI webinar will begin shortly Please mute your phone or microphone Please do not place the call on hold If you have difficulty with the quality of the connection then here
More informationBack to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office
Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office SAGE, Geneva 27 October 2009 Rebecca Martin Targeted Diseases and
More informationExpanded Programme on Immunization
1 Expanded Programme on Immunization Strategic issues Immunization is a cost-effective public health intervention that has dramatically reduced disease, disability and death in the Western Pacifi c Region.
More informationProgramme Update. Transition Independent Monitoring Board London, 2 November Geneva, 23 October 2017
Programme Update Transition Independent Monitoring Board London, 2 November 2017 On Behalf of GPEI - Michel Zaffran, Director Polio Eradication, WHO Geneva, 23 October 2017 1 Polio Eradication and Endgame
More informationWhy still Polio Donato Greco ECDC polio consultant 14 April 2016
Why still Polio Donato Greco ECDC polio consultant 14 April 2016 A medical student with the last texbook on Communicable diseases! Where there is no chapter on Poliomielitis!!! What can I say o Background
More informationPolio Eradication in India. Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014
Polio Eradication in India Dr Sunil Bahl Deputy Project Manager WHO Country Office for India 28 October 2014 History of Polio in India Number of Cases 200,000 200,000 OPV Introduced in RI - 1978 150,000
More informationHOA Outbreak Response assessment. Kenya 8 th to 12 th June 2015
HOA Outbreak Response assessment Kenya 8 th to 12 th June 2015 Subject areas of assessment Implementation of recommendation from previous assessment Quality of outbreak response AFP surveillance sensitivity
More informationGlobal Immunization Vision and Strategies (GIVS) Vaccine Tender , Pretender Meeting, Copenhagen December 2008
Global Immunization Vision and Strategies (GIVS) 2006-2015 Vaccine Tender 2010-2012, Pretender Meeting, Copenhagen 10-11 December 2008 Dr Ahmed Magan & Dr Osman David Mansoor Programme Division UNICEF
More informationMinistry of Health Viet Nam
Ministry of Health Viet Nam National Expanded Program on Immunization Comprehensive Multi-Year Plan cmyp for Extended Program on Immunization 2016-2020 Ha Noi, August 2015 Contents Acronyms... 1 Executive
More informationA SURVEY ON IMMUNIZATION COVERAGE AMONG CHILDREN OF RURAL SOUTH KERALA M. C. Vasantha Mallika 1, Siva Sree Ranga M. K 2
A SURVEY ON IMMUNIZATION COVERAGE AMONG CHILDREN OF RURAL SOUTH KERALA M. C. Vasantha Mallika 1, Siva Sree Ranga M. K 2 HOW TO CITE THIS ARTICLE: M. C. Vasantha Mallika, Siva Sree Ranga M. K. A Survey
More informationBULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN
BULLETIN World Health Organization Regional Office for the Western Pacific Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January
More informationProgress in maternal and child health: Uzbekistan and WHO European Region
Progress in maternal and child health: Uzbekistan and WHO European Region The National Model of Maternal and Child Health Protection in Uzbekistan: Zsuzsanna Jakab WHO Regional Director for Europe UZBEKISTAN
More informationCDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN
CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN 2010-2012 14 Sept-10 2010 First and Second Quarters (January June) Geographic distribution of wild poliovirus (WPV)
More informationUNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013
UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013 Presentation overview Scope of UNICEF procurement Overview of UNICEF procurement Vaccine market updates UNICEF procures
More informationPolio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions
Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions Global Polio Partners Group (PPG) meeting June 26, 2017 Underlying premise: Transition
More informationLegend: No confirmed case With confirmed case No case based data
Volume 11 Issue 10 ober ISSN 1814 3601 Figure 1. Distribution of measles with rash onset 1 30 tember, WHO Western Pacific Region Legend: No case With case No case based data Dots are placed at rom within
More informationGlobal Measles and Rubella Update November 2018
Global Measles and Rubella Update November 218 Measles Number of Reported Measles by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug Sep
More informationMeasles. Phases of accelerated measles control activities (measles mortality reduction and measles elimination) are indicated in Appendix 80_5.
Program Management 80_1 With renewed global commitment to achieving measles mortality reduction, the 2003 World Health Assembly stressed the importance of achieving the goals adopted by the United Nations
More informationPakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received
More informationPolio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September
Polio: A Global Update DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September 27. 2017 1 Polio Eradication and Endgame Strategy 1. Poliovirus detection & interruption 2. OPV2 withdrawal, IPV introduction,
More informationPolio Eradication and Surveillance. December
Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication
More informationFigure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region
Volume 8 Issue 9 tember 2014 ISSN 1814 3601 Figure 1. Distribution of confirmed measles cases with rash onset 1 31 ust 2014, WHO Western Pacific Region 1 dot = 1 case Legend: No confirmed case With confirmed
More informationStatus of Outbreak Vulnerable Countries
Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries
More informationIncreasing immunization coverage at the health facility level
WHO/V&B/02.27 ORIGINAL: ENGLISH Increasing immunization coverage at the health facility level WHO Vaccines and Biologicals World Health Organization United Nations Children s Fund WHO/V&B/02.27 ORIGINAL:
More informationNigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision
Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received
More informationGlobal Measles and Rubella Update October 2018
Global Measles and Rubella Update October 218 Measles Number of Reported Measles Cases by WHO Regions 218 Region Member States* Suspected cases Measles cases Clin Epi Lab Jan Feb Mar Apr May Jun Jul Aug
More informationHighlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance
No. 17 (September 2011) A monthly publication on vaccine preventable diseases and immunization data and analysis Issue 15, April 2011 Highlighting in the WHO European Region: measles outbreaks rubella
More informationUpdate on Status of Wild Poliovirus Outbreak in Kenya. 9 th Meeting of the IMB 1-3 October 2013 London, UK
Update on Status of Wild Poliovirus Outbreak in Kenya 9 th Meeting of the IMB 1-3 October 2013 London, UK Contents Background Confirmation and Immediate Response High Risk Areas Coordination of Response
More information